Extended-Spectrum Beta-Lactamase-Producing E. Coli and Klebsiella Pneumoniae in Children at University Pediatric Clinic in Skopje
Journal
Macedonian Journal of Medical Sciences
Date Issued
2009-03
Author(s)
Gordana Jankoska
Biljana Kjurcik-Trajkovska
Abstract
Aim. The objectives of this study were to determine the prevalence and antibiotic
susceptibility patterns of extended-spectrum β-lactamases (ESBL)-producing
Escherichia coli and Klebsiella pneumoniae.
Material and methods. E. coli and K. pneumoniae were obtained from all clinical
samples of hospitalized children.
Results. During one year period, 212 strains of E. coli and 103 strains of K.
pneumoniae were isolated. Of these, the ESBL production was observed in 26
(11.8%) isolates of E. coli and 25 (24.3%) isolates of K. pneumoniae. ESBLproducing E. coli isolates were commonly recovered from the respiratory tract
(21.4%) and urine (7.2%). ESBL-positive K. pneumoniae was commonly recovered
from urine (38.5%) and respiratory tract (18.7%). ESBL-positive E. coli isolates were
more susceptible to AMC (76%) and SXT (50%), than were the isolates of ESBLpositive K. pneumoniae (40% and 32%). Considering aminoglycosides, 92% of
ESBL-positive E. coli and 60% of ESBL-positive K. pneumoniae were susceptible
to amikacin vs. 23% and 40% of ESBL-positive E. coli and K. pneumoniae strains
to gentamicin. ESBL-positive K. pneumoniae strains were more susceptible to
ciprofloxacin (84%) than ESBL-positive strains of E. coli (38%). Cefepime shows
the best in vitro activity of tested cephalosporins (58% for E. coli and 72% for K.
pneumoniae). All isolates were susceptible to imipenem.
Conclusion. ESBL-producing E. coli and K. pneumoniae are present in our
hospital environment. It’s necessary and useful to perform screening and confirmatory tests for phenotypic detection of those organisms in a routine work. Most
of ESBL-producers are resistant to many classes of antibiotic, resulting in limited
treatment options.
OPEN²ACCESS
Introduction
Bacterial antibiotic resistance has become a
major clinical concern worldwide. Recently, the use of
second and third generation cephalosporins has led to
the selection of Gram-negative organisms resistan
susceptibility patterns of extended-spectrum β-lactamases (ESBL)-producing
Escherichia coli and Klebsiella pneumoniae.
Material and methods. E. coli and K. pneumoniae were obtained from all clinical
samples of hospitalized children.
Results. During one year period, 212 strains of E. coli and 103 strains of K.
pneumoniae were isolated. Of these, the ESBL production was observed in 26
(11.8%) isolates of E. coli and 25 (24.3%) isolates of K. pneumoniae. ESBLproducing E. coli isolates were commonly recovered from the respiratory tract
(21.4%) and urine (7.2%). ESBL-positive K. pneumoniae was commonly recovered
from urine (38.5%) and respiratory tract (18.7%). ESBL-positive E. coli isolates were
more susceptible to AMC (76%) and SXT (50%), than were the isolates of ESBLpositive K. pneumoniae (40% and 32%). Considering aminoglycosides, 92% of
ESBL-positive E. coli and 60% of ESBL-positive K. pneumoniae were susceptible
to amikacin vs. 23% and 40% of ESBL-positive E. coli and K. pneumoniae strains
to gentamicin. ESBL-positive K. pneumoniae strains were more susceptible to
ciprofloxacin (84%) than ESBL-positive strains of E. coli (38%). Cefepime shows
the best in vitro activity of tested cephalosporins (58% for E. coli and 72% for K.
pneumoniae). All isolates were susceptible to imipenem.
Conclusion. ESBL-producing E. coli and K. pneumoniae are present in our
hospital environment. It’s necessary and useful to perform screening and confirmatory tests for phenotypic detection of those organisms in a routine work. Most
of ESBL-producers are resistant to many classes of antibiotic, resulting in limited
treatment options.
OPEN²ACCESS
Introduction
Bacterial antibiotic resistance has become a
major clinical concern worldwide. Recently, the use of
second and third generation cephalosporins has led to
the selection of Gram-negative organisms resistan
File(s)![Thumbnail Image]()
Loading...
Name
MJMS-ESBL in pediatric clinic-2009.pdf
Size
311.06 KB
Format
Adobe PDF
Checksum
(MD5):9d6cf312b5a41c689b44457be7bccf28